Great Novel Therapeutics Biotech & Medicals (7427.TWO)
TWD 36.5
(11.11%)
TWD 36.5
(11.11%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -165.17 Million TWD | -49.82% |
| 2022 | -110.24 Million TWD | -78.02% |
| 2021 | -61.92 Million TWD | 7.5% |
| 2020 | -66.94 Million TWD | -169.13% |
| 2019 | -24.87 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -335.27 Million TWD | -102.98% |
| 2024 Q2 | -335.27 Million TWD | 0.86% |
| 2023 Q4 | -165.17 Million TWD | 2.07% |
| 2023 FY | -165.17 Million TWD | -49.82% |
| 2023 Q3 | -168.67 Million TWD | 16.62% |
| 2023 Q2 | -202.29 Million TWD | 1.38% |
| 2023 Q1 | -205.12 Million TWD | -86.06% |
| 2022 Q3 | -111.07 Million TWD | 0.0% |
| 2022 FY | -110.24 Million TWD | -78.02% |
| 2022 Q4 | -110.24 Million TWD | 0.75% |
| 2021 FY | -61.92 Million TWD | 7.5% |
| 2020 FY | -66.94 Million TWD | -169.13% |
| 2019 FY | - TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 37.473% |
| Level Biotechnology Inc. | -453.9 Million TWD | 63.61% |
| Sagittarius Life Science Corp | -120.57 Million TWD | -36.996% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | 15.897% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 133.045% |
| GlycoNex Incorporation | -148.56 Million TWD | -11.179% |
| VBI | -25.31 Million TWD | -552.457% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 510.212% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 219.697% |
| Visgeneer Inc. | 31.28 Million TWD | 627.989% |
| Mycenax Biotech Inc. | 207 Million TWD | 179.792% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 75.731% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | -23.034% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 126.575% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -186.475% |
| Enimmune corporation | -314.15 Million TWD | 47.423% |
| TaiRx, Inc. | -147.86 Million TWD | -11.704% |
| CHO Pharma, Inc. | -203.79 Million TWD | 18.949% |
| EirGenix Inc. | -4.58 Billion TWD | 96.4% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -94.868% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 236.655% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 94.867% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 47.963% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | -733.675% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 619.274% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 425.438% |
| RBC Bioscience Corporation | 422.18 Million TWD | 139.124% |
| BiOptic Inc. | 12.59 Million TWD | 1411.753% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 82.51% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -62.757% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 152.458% |
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -114.392% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 37.095% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 640.179% |
| Neith Corporation | -150.31 Million TWD | -9.889% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -156.799% |
| NaviFUS Corp. | -123.12 Million TWD | -34.149% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 323.057% |
| Sinew Pharma Inc. | -160.34 Million TWD | -3.013% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 31.715% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 51.041% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 59.971% |
| AP Biosciences Inc | -196.52 Million TWD | 15.953% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 123.982% |
| 3D Global Biotech Inc. | -11.43 Million TWD | -1344.225% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 80.092% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 112.169% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 60.187% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 21.096% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | -14.815% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 50.029% |
| TCI GENE Inc. | -689.25 Million TWD | 76.035% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -38.876% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 87.384% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 906.405% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -62.144% |
| PharmaEngine, Inc. | -860.8 Million TWD | 80.812% |
| Savior Lifetec Corporation | -812.54 Million TWD | 79.672% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 44.935% |
| OBI Pharma, Inc. | -398.22 Million TWD | 58.522% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 54.798% |
| Acepodia, Inc. | -6.02 Billion TWD | 97.256% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 95.144% |